Interleukin-9 promotes tumorigenesis through augmenting angiogenesis in non-small cell lung cancer
Authors:
- 1 October 2019
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 75, 105766
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81802512)
This publication has 23 references indexed in Scilit:
- Involvement of IL-9 in Th17-Associated Inflammation and Angiogenesis of PsoriasisPLOS ONE, 2013
- A Brief History of IL-9The Journal of Immunology, 2011
- IL-4 inhibits TGF-β-induced Foxp3+ T cells and, together with TGF-β, generates IL-9+ IL-10+ Foxp3− effector T cellsNature Immunology, 2008
- Transforming growth factor-β 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9–producing subsetNature Immunology, 2008
- Autocrine release of interleukin-9 promotes Jak3-dependent survival of ALK+ anaplastic large-cell lymphoma cellsBlood, 2006
- IL-9 and its Receptor: From Signal Transduction to TumorigenesisGrowth Factors, 2004
- Increased serum levels of interleukin-9 correlate to negative prognostic factors in Hodgkin's lymphomaLeukemia, 2003
- Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumoursEuropean Journal of Cancer, 2002
- Heteromerization of the γc Chain with the Interleukin-9 Receptor α Subunit Leads to STAT Activation and Prevention of ApoptosisJournal of Biological Chemistry, 1998
- Cloning and characterization of a cDNA for a new mouse T cell growth factor (P40).Journal of Experimental Medicine, 1989